Title page
Contents
Executive summary 4
Acknowledgements 5
1. Tuberculosis screening clinics 6
2. Methods 9
3. Demographics of all applicants 10
4. Diagnostic tests and case detection 12
5. Conclusion 24
6. References 26
7. Appendices 29
7.1. Case definition 29
7.2. Definitions of drug susceptibility terms 29
Table 1. Sputum smears and culture test results for individuals tested between January and December 2017 by IOM clinics 14
Figure 1. Map of the countries in the UK pre-entry screening programme and the phase in which each country joined 8
Figure 2. Distribution of all applicants by age group and sex, 2017 10
Figure 3. Number of applicants by region for the last 3 years, 2015-2017 11
Figure 4. Flow-through of IOM data, January to December 2017 13
Figure 5. CXR positivity and applicants' TB detection rate by country, January to December 2017 15
Figure 6. IOM sputum cultures as a proportion of sputum smears by screening year 16
Figure 7. Annual number of TB cases and detection rates, January 2006 to December 2017 17
Figure 8. TB detection rates by age group by year, 2015-2017 18
Figure 9. TB detection rates in the 20 countries with the largest number of applicants for years 2015-2017 19
Figure 10. TB detection rates by applicant visa type, 2015-2017 20
Figure 11. Trends in drug susceptibility testing, 2007 to 2017 21
Figure 12. Summary of drug susceptibility patterns for the 702 positive TB cultures, 2007 to 2017 22
Figure 13. Number of TB cases diagnosed by pre-entry screening in the 101 programme countries and those identified within one year of UK entry, 2006 to 2017 23